Bevacizumab

Bevacizumab is a prescription medication used to treat a variety of cancers. It is used in combination with other cancer treatments such as chemotherapy, radiation, or surgery. It works by blocking a protein called Vascular Endothelial Growth Factor (VEGF) that helps in the growth and spread of cancer cells. Bevacizumab can be used to treat cancers such as metastatic colorectal cancer, metastatic non-small cell lung cancer, metastatic renal cell carcinoma, glioblastoma, pancreatic cancer, and cervical cancer.

Bevacizumab, sold under the brand name Avastin among others, is a medication used to treat a number of types of cancers and a specific eye disease . It is a monoclonal antibody, which is a type of protein that is designed to target and destroy specific cells.

Bevacizumab works by blocking the growth of new blood vessels, which tumors need to grow and spread. It is given by injection into a vein (intravenously) for cancer treatment, and by injection into the eye (intravitreally) for age-related macular degeneration.

Bevacizumab is used in combination with other cancer treatments, such as chemotherapy or surgery. It is not a cure for cancer, but it can help to slow the growth of the cancer and improve survival rates.

Bevacizumab can cause serious side effects, including high blood pressure, bleeding, and protein in the urine. It is important to talk to your doctor about the risks and benefits of bevacizumab before starting treatment.

Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01F - Monoclonal antibodies and antibody drug conjugates
L01FG VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors
Anatomical Therapeutic Chemical Classification
S - Sensory organs
S01 Ophthalmologicals
S01L - Ocular vascular disorder agents
S01LA Antineovascularisation agents
External Links